Product Information
CARBAMAZEPINE 100 MG/5 ML SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0969 per ML under NDC 70954024010. Its NADAC has been published 181 times since Jan 11, 2023.
Strength
100 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954024010
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA214277On Market Since
10/6/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has been published 181 times since Jan 11, 2023, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0969 per ML |
|---|---|
| All-time high | $0.1345 (Jan 10, 2024) |
| All-time low | $0.0969 (Jun 17, 2026) |
| 52-week high | $0.1134 |
| 52-week low | $0.0969 |
| Median price | $0.1114 |
| Average price | $0.1114 |
| Largest weekly change | +26.0% (May 17, 2023) |
| Weeks tracked | 181 |
| Tracking since | Jan 11, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 100 MG/5 ML SUSP, manufactured by ANI Pharmaceuticals, Inc., is $0.0969 per ML (NDC 70954024010), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has declined 13.3%. It has been tracked across 181 weekly CMS publications since Jan 11, 2023.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 100 MG/5 ML SUSP?
Since Jan 11, 2023, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has ranged from a low of $0.0969 (Jun 17, 2026) to a high of $0.1345 (Jan 10, 2024), with a median of $0.1114 per ML.
Are there cheaper alternatives to CARBAMAZEPINE 100 MG/5 ML SUSP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CARBAMAZEPINE 100 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures CARBAMAZEPINE 100 MG/5 ML SUSP?
CARBAMAZEPINE 100 MG/5 ML SUSP (NDC 70954024010) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification